Inhibition of Small-Conductance Calcium-Activated Potassium Current (IK,Ca) Leads to Differential Atrial Electrophysiological Effects in a Horse Model of Persistent Atrial Fibrillation
BackgroundSmall-conductance Ca2+-activated K+ (KCa2) channels have been proposed as a possible atrial-selective target to pharmacologically terminate atrial fibrillation (AF) and to maintain sinus rhythm. However, it has been hypothesized that the importance of the KCa2 current—and thereby the effic...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphys.2021.614483/full |
id |
doaj-f83aac8393b7445e81accc751b356660 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Merle Friederike Fenner Giulia Gatta Stefan Sattler Marion Kuiper Eva Melis Hesselkilde Eva Melis Hesselkilde Ditte M. T. Adler Morten Smerup Ulrich Schotten Ulrik Sørensen Jonas Goldin Diness Thomas Jespersen Sander Verheule Arne Van Hunnik Rikke Buhl |
spellingShingle |
Merle Friederike Fenner Giulia Gatta Stefan Sattler Marion Kuiper Eva Melis Hesselkilde Eva Melis Hesselkilde Ditte M. T. Adler Morten Smerup Ulrich Schotten Ulrik Sørensen Jonas Goldin Diness Thomas Jespersen Sander Verheule Arne Van Hunnik Rikke Buhl Inhibition of Small-Conductance Calcium-Activated Potassium Current (IK,Ca) Leads to Differential Atrial Electrophysiological Effects in a Horse Model of Persistent Atrial Fibrillation Frontiers in Physiology persistent atrial fibrillation atrial selectivity SK/KCa2 channels NS8593 epicardial contact mapping AF conduction |
author_facet |
Merle Friederike Fenner Giulia Gatta Stefan Sattler Marion Kuiper Eva Melis Hesselkilde Eva Melis Hesselkilde Ditte M. T. Adler Morten Smerup Ulrich Schotten Ulrik Sørensen Jonas Goldin Diness Thomas Jespersen Sander Verheule Arne Van Hunnik Rikke Buhl |
author_sort |
Merle Friederike Fenner |
title |
Inhibition of Small-Conductance Calcium-Activated Potassium Current (IK,Ca) Leads to Differential Atrial Electrophysiological Effects in a Horse Model of Persistent Atrial Fibrillation |
title_short |
Inhibition of Small-Conductance Calcium-Activated Potassium Current (IK,Ca) Leads to Differential Atrial Electrophysiological Effects in a Horse Model of Persistent Atrial Fibrillation |
title_full |
Inhibition of Small-Conductance Calcium-Activated Potassium Current (IK,Ca) Leads to Differential Atrial Electrophysiological Effects in a Horse Model of Persistent Atrial Fibrillation |
title_fullStr |
Inhibition of Small-Conductance Calcium-Activated Potassium Current (IK,Ca) Leads to Differential Atrial Electrophysiological Effects in a Horse Model of Persistent Atrial Fibrillation |
title_full_unstemmed |
Inhibition of Small-Conductance Calcium-Activated Potassium Current (IK,Ca) Leads to Differential Atrial Electrophysiological Effects in a Horse Model of Persistent Atrial Fibrillation |
title_sort |
inhibition of small-conductance calcium-activated potassium current (ik,ca) leads to differential atrial electrophysiological effects in a horse model of persistent atrial fibrillation |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Physiology |
issn |
1664-042X |
publishDate |
2021-02-01 |
description |
BackgroundSmall-conductance Ca2+-activated K+ (KCa2) channels have been proposed as a possible atrial-selective target to pharmacologically terminate atrial fibrillation (AF) and to maintain sinus rhythm. However, it has been hypothesized that the importance of the KCa2 current—and thereby the efficacy of small-conductance Ca2+-activated K+ current (IK,Ca) inhibition—might be negatively related to AF duration and the extent of AF-induced remodeling.Experimental Approach and MethodsTo address the hypothesis of the efficacy of IK,Ca inhibition being dependent on AF duration, the anti-arrhythmic properties of the IK,Ca inhibitor NS8593 (5 mg/kg) and its influence on atrial conduction were studied using epicardial high-density contact mapping in horses with persistent AF. Eleven Standardbred mares with tachypacing-induced persistent AF (42 ± 5 days of AF) were studied in an open-chest experiment. Unipolar AF electrograms were recorded and isochronal high-density maps analyzed to allow for the reconstruction of wave patterns and changes in electrophysiological parameters, such as atrial conduction velocity and AF cycle length. Atrial anti-arrhythmic properties and adverse effects of NS8593 on ventricular electrophysiology were evaluated by continuous surface ECG monitoring.ResultsIK,Ca inhibition by NS8593 administered intravenously had divergent effects on right and left AF complexity and propagation properties in this equine model of persistent AF. Despite global prolongation of AF cycle length, a slowing of conduction in the right atrium led to increased anisotropy and electrical dissociation, thus increasing AF complexity. In contrast, there was no significant change in AF complexity in the LA, and cardioversion of AF was not achieved.ConclusionsIntra-atrial heterogeneity in response to IK,Ca inhibition by NS8593 was observed. The investigated dose of NS8593 increased the AF cycle length but was not sufficient to induce cardioversion. In terms of propagation properties during AF, IK,Ca inhibition by NS8593 led to divergent effects in the right and left atrium. This divergent behavior may have impeded the cardioversion success. |
topic |
persistent atrial fibrillation atrial selectivity SK/KCa2 channels NS8593 epicardial contact mapping AF conduction |
url |
https://www.frontiersin.org/articles/10.3389/fphys.2021.614483/full |
work_keys_str_mv |
AT merlefriederikefenner inhibitionofsmallconductancecalciumactivatedpotassiumcurrentikcaleadstodifferentialatrialelectrophysiologicaleffectsinahorsemodelofpersistentatrialfibrillation AT giuliagatta inhibitionofsmallconductancecalciumactivatedpotassiumcurrentikcaleadstodifferentialatrialelectrophysiologicaleffectsinahorsemodelofpersistentatrialfibrillation AT stefansattler inhibitionofsmallconductancecalciumactivatedpotassiumcurrentikcaleadstodifferentialatrialelectrophysiologicaleffectsinahorsemodelofpersistentatrialfibrillation AT marionkuiper inhibitionofsmallconductancecalciumactivatedpotassiumcurrentikcaleadstodifferentialatrialelectrophysiologicaleffectsinahorsemodelofpersistentatrialfibrillation AT evamelishesselkilde inhibitionofsmallconductancecalciumactivatedpotassiumcurrentikcaleadstodifferentialatrialelectrophysiologicaleffectsinahorsemodelofpersistentatrialfibrillation AT evamelishesselkilde inhibitionofsmallconductancecalciumactivatedpotassiumcurrentikcaleadstodifferentialatrialelectrophysiologicaleffectsinahorsemodelofpersistentatrialfibrillation AT dittemtadler inhibitionofsmallconductancecalciumactivatedpotassiumcurrentikcaleadstodifferentialatrialelectrophysiologicaleffectsinahorsemodelofpersistentatrialfibrillation AT mortensmerup inhibitionofsmallconductancecalciumactivatedpotassiumcurrentikcaleadstodifferentialatrialelectrophysiologicaleffectsinahorsemodelofpersistentatrialfibrillation AT ulrichschotten inhibitionofsmallconductancecalciumactivatedpotassiumcurrentikcaleadstodifferentialatrialelectrophysiologicaleffectsinahorsemodelofpersistentatrialfibrillation AT ulriksørensen inhibitionofsmallconductancecalciumactivatedpotassiumcurrentikcaleadstodifferentialatrialelectrophysiologicaleffectsinahorsemodelofpersistentatrialfibrillation AT jonasgoldindiness inhibitionofsmallconductancecalciumactivatedpotassiumcurrentikcaleadstodifferentialatrialelectrophysiologicaleffectsinahorsemodelofpersistentatrialfibrillation AT thomasjespersen inhibitionofsmallconductancecalciumactivatedpotassiumcurrentikcaleadstodifferentialatrialelectrophysiologicaleffectsinahorsemodelofpersistentatrialfibrillation AT sanderverheule inhibitionofsmallconductancecalciumactivatedpotassiumcurrentikcaleadstodifferentialatrialelectrophysiologicaleffectsinahorsemodelofpersistentatrialfibrillation AT arnevanhunnik inhibitionofsmallconductancecalciumactivatedpotassiumcurrentikcaleadstodifferentialatrialelectrophysiologicaleffectsinahorsemodelofpersistentatrialfibrillation AT rikkebuhl inhibitionofsmallconductancecalciumactivatedpotassiumcurrentikcaleadstodifferentialatrialelectrophysiologicaleffectsinahorsemodelofpersistentatrialfibrillation |
_version_ |
1724277903912337408 |
spelling |
doaj-f83aac8393b7445e81accc751b3566602021-02-09T06:10:07ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2021-02-011210.3389/fphys.2021.614483614483Inhibition of Small-Conductance Calcium-Activated Potassium Current (IK,Ca) Leads to Differential Atrial Electrophysiological Effects in a Horse Model of Persistent Atrial FibrillationMerle Friederike Fenner0Giulia Gatta1Stefan Sattler2Marion Kuiper3Eva Melis Hesselkilde4Eva Melis Hesselkilde5Ditte M. T. Adler6Morten Smerup7Ulrich Schotten8Ulrik Sørensen9Jonas Goldin Diness10Thomas Jespersen11Sander Verheule12Arne Van Hunnik13Rikke Buhl14Department of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Taastrup, DenmarkDepartment of Physiology, Cardiovascular Research Institute Maastricht, Maastricht, NetherlandsDepartment of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DenmarkDepartment of Physiology, Cardiovascular Research Institute Maastricht, Maastricht, NetherlandsDepartment of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Taastrup, DenmarkDepartment of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DenmarkDepartment of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Taastrup, DenmarkDepartment of Cardiothoracic Surgery, The Heart Centre, Copenhagen University Hospital, Copenhagen, DenmarkDepartment of Physiology, Cardiovascular Research Institute Maastricht, Maastricht, NetherlandsAcesion Pharma ApS, Copenhagen, DenmarkAcesion Pharma ApS, Copenhagen, DenmarkDepartment of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DenmarkDepartment of Physiology, Cardiovascular Research Institute Maastricht, Maastricht, NetherlandsDepartment of Physiology, Cardiovascular Research Institute Maastricht, Maastricht, NetherlandsDepartment of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Taastrup, DenmarkBackgroundSmall-conductance Ca2+-activated K+ (KCa2) channels have been proposed as a possible atrial-selective target to pharmacologically terminate atrial fibrillation (AF) and to maintain sinus rhythm. However, it has been hypothesized that the importance of the KCa2 current—and thereby the efficacy of small-conductance Ca2+-activated K+ current (IK,Ca) inhibition—might be negatively related to AF duration and the extent of AF-induced remodeling.Experimental Approach and MethodsTo address the hypothesis of the efficacy of IK,Ca inhibition being dependent on AF duration, the anti-arrhythmic properties of the IK,Ca inhibitor NS8593 (5 mg/kg) and its influence on atrial conduction were studied using epicardial high-density contact mapping in horses with persistent AF. Eleven Standardbred mares with tachypacing-induced persistent AF (42 ± 5 days of AF) were studied in an open-chest experiment. Unipolar AF electrograms were recorded and isochronal high-density maps analyzed to allow for the reconstruction of wave patterns and changes in electrophysiological parameters, such as atrial conduction velocity and AF cycle length. Atrial anti-arrhythmic properties and adverse effects of NS8593 on ventricular electrophysiology were evaluated by continuous surface ECG monitoring.ResultsIK,Ca inhibition by NS8593 administered intravenously had divergent effects on right and left AF complexity and propagation properties in this equine model of persistent AF. Despite global prolongation of AF cycle length, a slowing of conduction in the right atrium led to increased anisotropy and electrical dissociation, thus increasing AF complexity. In contrast, there was no significant change in AF complexity in the LA, and cardioversion of AF was not achieved.ConclusionsIntra-atrial heterogeneity in response to IK,Ca inhibition by NS8593 was observed. The investigated dose of NS8593 increased the AF cycle length but was not sufficient to induce cardioversion. In terms of propagation properties during AF, IK,Ca inhibition by NS8593 led to divergent effects in the right and left atrium. This divergent behavior may have impeded the cardioversion success.https://www.frontiersin.org/articles/10.3389/fphys.2021.614483/fullpersistent atrial fibrillationatrial selectivitySK/KCa2 channelsNS8593epicardial contact mappingAF conduction |